Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03042897

Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer

Endometrial Cancer and Obesity: An Exercise and Diet Intervention for Weight Loss

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
Female
Age
19 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies exercise and diet intervention in promoting weight loss in obese patients with stage I endometrial cancer. Exercise and diet may cause weight loss and minimize the risk of gynecologic surgery related to being overweight in patients with endometrial cancer.

Detailed description

PRIMARY OBJECTIVES: I. To determine if participation in a 16-week exercise and diet intervention would elicit weight loss, assessed by a 10% decrease in fat mass, in endometrial cancer (EC) patients. SECONDARY OBJECTIVES: I. To determine if participation in a 16-week exercise and diet intervention would improve cardiorespiratory fitness (CRF) and muscular strength. TERTIARY OBJECTIVES: I. To determine if participation in a 16-week exercise and diet intervention could improve quality of life (QOL), fatigue, and depression. II. To determine the effects of a 16-week exercise and diet intervention on cardiovascular (CV) health. OUTLINE: Patients undergo aerobic exercise thrice weekly over 95 minutes for up to 16 weeks. Patients also undergo multi-lifestyle interventions based on the dietary approaches to stop hypertension (DASH) diet once weekly over 1 hour for up to 16 weeks. After completion of study, patients are followed up for 16 weeks. After completion of study, patients are followed up for 16 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary InterventionUndergo DASH diet
BEHAVIORALExercise InterventionUndergo in aerobic exercise
OTHERLaboratory Biomarker AnalysisCorrelative studies
OTHERQuality-of-Life AssessmentAncillary studies

Timeline

Start date
2017-09-08
Primary completion
2019-07-31
Completion
2019-07-31
First posted
2017-02-03
Last updated
2020-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03042897. Inclusion in this directory is not an endorsement.